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ABSTRACT 
The efficient removal of a N- or C-terminal purification tag from a 
fusion protein is necessary to obtain a protein in a pure and active form, 
ready for use in human or animal medicine. Current echniques based on 
enzymatic leavage are expensive and result in the presence of addi- 
tional amino acids at either end of the proteins, as well as contaminating 
proteases in the preparation. Here we evaluate an alternative method to 
the one-step affinity/protease purification process for large-scale purifi- 
cation. It is based upon the cyanogen bromide (CNBr) cleavage at a sin- 
gle methionine placed in between a histidine tag and a Plasmodium 
falciparum antigen. The C-terminal segment of the circumsporozoite 
polypeptide was expressed as a fusion protein with a histidine tag in 
Escherichia coli purified by Ni-NAT agarose column chromatography and 
subsequently cleaved by CNBr to obtain a polypeptide without any 
extraneous amino acids derived from the cleavage site or from the affin- 
ity purification tag. Thus, a recombinant protein is produced without he 
need for further purification, demonstrating that CNBr cleavage is a pre- 
cise, efficient, and low-cost alternative to enzymatic digestion, and can 
be applied to large-scale preparations of recombinant proteins. 
Index Entries: Recombinant polypeptide; polypeptide purification; 
affinity chromatography; CNBr cleavage. 
*Author to whom all correspondence and reprint requests hould be addressed. 
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INTRODUCTION 
Recombinant proteins have been produced in various organisms. 
Bacteria, yeast, insect and mammalian cells, and viral systems are among 
the most commonly used systems today. Optimal expression is often 
obtained by compromising the choice of host cells with the expression sys- 
tem, while evaluating advantages and drawbacks. However, in all cases, 
the production at low cost of relevant proteins depends not only on the 
expression system, but also on the required purification step(s). Indeed, 
reducing the number of downstream processing steps is essential to render 
the commercial use of recombinant proteins more attractive. Recombinant 
proteins have been purified based on either their chemical properties or by 
immunoaffinity using specific antibodies. New purification procedures 
have been based on the addition of a peptidic tag to these proteins allow- 
ing affinity or immunoaffinity purification. For example, gluthation-S- 
transferase- (1) or histidine tags (2) have allowed successful one-step 
purifications of recombinant proteins. In these cases, the purified products 
have been used directly, or the tags have been removed prior to use. In the 
latter case, cleavage sites for thrombin (1), enterokinase (3), or Factor X (4) 
have been inserted in between the tag and the desired polypeptide, which 
then enables proteolytic leavage and purification on an affinity column to 
remove the tag. Although recombinant proteins are purified rapidly using 
this strategy, the end product usually contains everal extra amino acids 
and is contaminated by the proteolytic enzyme. Additional purification 
steps could be necessary. Furthermore, these extra amino acids on the 
polypeptide of interest as well as the presence of the proteolytic enzyme 
could influence the activity and/or possibly trigger unwanted immune 
responses in humans or animals, rendering the recombinant protein inad- 
equate for in vivo studies. Furthermore, these purification steps involving 
enzymatic leavage steps are expensive and, thus, inappropriate for large- 
scale production of proteins. 
All these considerations taken together prompted us to investigate a 
simple, rapid, and efficient procedure for the large-scale purification of 
recombinant polypeptides. Cyanogen bromide (CNBr), under precise con- 
ditions, has been known for its ability to cleave polypeptides specifically 
at methionine and has been used specifically for the cleavage of two proin- 
sulin molecules expressed in Escherichia coli (5). We have first performed 
purification by immobilized metal ion-affinity chromatography (IMAC) 
(6), which is based on the presence of a histidine tag. It was followed by 
CNBr cleavage of the tag at a methionine placed between the tag and the 
polypeptide to be purified. In this article, we present he purification of a 
C-terminal segment of the circumsporozoite protein (CSP) of the malaria 
agent, Plasmodium falciparum produced in E. coil 
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MATERIALS AND METHODS 
Reagents 
All restriction and modification enzymes used were purchased from 
Boehringer Mannheim (Mannheim, Germany) or Gibco BRL (Gaithers- 
burg, MD). Oligonucleotides were obtained from MWG-Biotech (GmbH, 
Ebersberg, Germany). Bacterial media and culture conditions have been 
previously described (7). 
DNA Construct 
To obtain expression of the C-terminal segment (103 amino acids) of 
P. falciparum CSP, we used the vector pET9a (Promega, Madison, WI). This 
vector contains aT7 RNA polymerase gene, which is under the control of 
the LacUv5 promotor. Such a promotor can be induced by isopropyl-thio- 
~-D-galactoside (IPTG) and, thus, controls the expression of the T7 RNA 
polymerase. To obtain T7-regulated expression ofthe region coding for the 
C-terminal segment of CSP (P. falciparum strain NF-54) (8), we amplified 
the segment of the CSP gene corresponding to amino acid 282-383 by PCR 
using specific oligonucleotides. The 5'-amplimer hybridized to 38 
nucleotides of the CSP gene (8). Upstream of the CSP sequence, the 5'- 
amplimer contained the NheI restriction site and six nucleotides (ATG- 
GAA), coding for methionine and aspartic acid. The 3'-amplimer 
hybridized to 23 nucleotides of the CSP gene which enabled the insertion 
of an in-frame UAA and SacI restriction site into the gene. This 3'- 
amplimer also allowed us to change methionine 379 (8). After amplifica- 
tion and digestion with NheI and SacI, the DNA fragment was inserted into 
the pET9a vector. This region was completely sequenced in order to con- 
firm the presence of the correct open reading frame. As expected, the open 
reading frame contained the initiation codon, the six histidine residues, the 
methionine residue at position 15, two valine residues at position 28 and 
114, and a stop codon. Thus, this open reading frame could code for a 
polypeptide of 118 amino acids in its complete form and of 103 amino 
acids polypeptide after cleavage of the affinity tag (Fig. 1A). 
Cell tysis 
A single colony containing the expression plasmid was used to inoc- 
ulate 2.5 L of LB broth medium containing 50 ~g/mL of kanamycin. The 
culture was grown at 37~ with vigorous haking until the A600 reached 0.8. 
IPTG was added to a final concentration f 1 raM, and the culture was 
incubated for an additional 3h at 37~ Cells were harvested by centrifu- 
gation at 4000 rpm for 15 min, resuspended in 10 mL 0.1 M Na2HPO4, 0.01 
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Fig 1. (A) Amino acid sequence of the P. falciparum C-terminal segment of CSP (PfCS C-ter) fused to 
a purification tag for expression i E. coli. The methionine residues (positions 12 and 15) present in the 
purification tag sequence and the two valine residues (positions 28 and 105) replacing the methionines 
of the CSP are shown in bold. (B} Analysis of different clones expressing PfCS C-ter. Protein lysates 
were separated on SDS PAGE 15%, transferred onto nitro cellulose, and stained with Ponceau red. 
Total lyaste of an E. coli colony transformed with the control vector (pET9a) is shown in lane a. Total 
lysates of seven independent bacterial colonies transformed with PfCS C-ter construct are shown in 
lanes b-g. The molecular-mass markers 14.4, 21.5 and 31.0 kDa (Bio-Rad, Hercules, CA, low range) are 
indicated. (C) Immunodetection f the PfCS C-ter in the E. coli clones hown in (B). Immunodetection 
was performed using the S5III serum (lanes a-g) at a dilution of 1:2000. The molecular-mass markers 
14.4, 21.5, and 31.0 kDa (Bio~ low range) are indicated. (D) Purification of the PfCS C-ter on the 
Ni-NTA agarose resin. Total lysate of an E. coli colony transformed with the PfCS C-ter vector (lane a) 
and fractions eluted at 10 mM (lane b), 30 mM (lane c), and 50 mM (lane d) were analyzed by SDS- 
PAGE. Coomassie blue (lanes a-d) and silver nitrate (lane e-h) stainings are shown. The molecular- 
mass markers 14.4, 21.5, 31.0, and 45.0 kDa (Bio-Rad, low range) are indicated. 
Applied Biochemistry and Biotechnology 98 Vol. 74, 1998 
Recombinant Polypeptide and CNBr Cleavage 99 
M Tris, pH adjusted to 8.0 with H3PO4, and lysed in a French press. Urea 
was added to 8 M (final concentration) and the obtained solution cen- 
trifuged at 9780 g for 15 min. The supernatant was collected, and ~-mer- 
captoethanol added to a final concentration f 10 mM. 
IMAC and CNBr Cleavage 
The cell lysate was incubated in batch for 1 h at room temperature 
with 25 mL Ni-NTA agarose resin (Qiagen Inc., Chatsworth, CA, USA). 
The resin had been previously equilibrated with buffer A (8 M urea, 0.1 M 
Na2HPO4, 0.01 M Tris, pH adjusted to 8.0 with HBPO4). The column was 
prepared as follows: lysate-coupled resin was poured at a rate of 60 mL/h 
flow rate, washed with 120 mL of buffer A, and then the material was 
eluted (flow rate 60 mL/h) with buffer B (8 M urea, 0.1 M Na2HPO4, 0.01 
M Tris, pH adjusted to 6.3 with HgPO4) containing increasing concentra- 
tions of imidazole (10, 30, 50, 250 mM). 
The eluted material was desalted by a Sephadex G25 column (50 • 
2.5 cm using 50% acetic acid/H20 as mobile phase), lyophilized, and 
treated for 8 h at room temperature ata concentration f 20 mg/mL in 70% 
TFA using a 100-fold molar excess of CNBr. The digested material was 
lyophilized, solubilized in buffer A, and loaded again on the Ni-NTA 
agarose column. The flow through of the column was desalted by a 
Sephadex G25 column (50 • 2.5 cm using 50% acetic acid/H20 as mobile 
phase) and lyophilized. Approximatively 200 mg of over 95% pure CSP (as 
estimated by SDS-PAGE) was recovered from the 2.5-L culture. 
Mass Spectrometry 
MALDI-TOF mass analysis was performed using a time-of-flight 
mass spectrometer Voyager-DE (PerSeptive Biosystem, Framingham, MA) 
equipped with a nitrogen laser (K = 337 nm) to desorbe and ionize the 
sample. The accelerating voltage used was 30 kV. The sample (1 ~L; 
1 mg/mL) was mixed with 24 ~L of a saturated solution of trans-3,5- 
dimethoxy-4-hydroxycinnamic cid (sinapinic acid) (Sigma, St. Louis, MI) 
in 1:2 acetonitrile/1.0% TFA, and 1.0 ~L of this solution was placed into a 
well of the Voyager sample plate and air-dried at room temperature. Ion 
masses were assigned based on an external mass calibration using two 
points that bracketed the mass range of interest. Relative signal abun- 
dances in the MALDI spectra re not directly comparable to the relative 
abundances of the species owing to potential differences in sensitivities of
different substances. 
Applied Biachemistry and Biotechnology Vol. 74, 1998 
1 O0 Rais-Beghdadi et al. 
RESULTS AND DISCUSSION 
Expression of the C-terminal Segment of CSP in E. coli 
Using a commercially available prokaryotic expression system, we 
expressed the C-terminal segment of the CSP of P. falciparum (PfCS C-ter) in 
the E. coli DE3 bacterial strain using the vector pET9a. The open reading 
frame codes for a polypeptide of 118 amino acids in its complete form, and 
103 amino acids after cleavage of the affinity tag by CNBr (Fig. 1A). A 
polypeptide of approx 19 kDa is detectable in different bacterial colonies 
after SDS-PAGE separation, blotting onto nitrocellulose, and Ponceau red 
staining of whole cell lysates (Fig. 1B). As exemplified, the 19-kDa polypep- 
tide is present at very various levels in the different clones. In certain 
clones, the presence of the 19-kDa polypeptide is barely detectable (lanes b 
and c), whereas in others, it is one of the predominant polypeptides (lanes 
f and g). It was also confirmed as a CSP-containing polypeptide by immun- 
odetection using an antiserum directed specifically against he C-terminal 
segment of the CSP protein (Fig. 1C). No signal was observed in E. coli DE3 
transformed with the plasmid alone (Fig. 1C, lane a). 
Purification by IMAC of PfCS C-ter Palypeptide 
The presence of initiation of translation sequences and a histidine tag 
allows a one-step urification of the fusion protein by IMAC. Bacterial cell 
lysates were loaded onto a Ni-NTA agarose resin. After washing, the 
fusion protein was eluted in the presence of urea and increasing imidazole 
concentrations. The material was analyzed by SDS-PAGE Coomassie blue 
and silver nitrate stainings. The starting material (lanes a and f) and the 
material purified (lanes b-e and g-j) at 10, 30, 50, and 250 mM imidazole 
have been separated on SDS gels, and their pattern is compared (Fig. 1D). 
As evidenced in the figure, (Fig. 1D), elution was most efficient at 10 and 
30 mM imidazole, unlike conventional e ution profiles, which use up to 
250 mM imidazole. Such a discrepancy in the elution profiles is probably 
the result of the influence of the amino acid sequence of the polypeptide of
interest on the affinity of the histidine tail for the Ni-NTA agarose column. 
The identity of the material was verified by immunoblotting using an anti- 
CSP antibody (data not shown). Additional bands correspond to degraded 
products. 
CNBr Cleavage and Analytical Characterization 
of Purified PfCS C-ter 
In order to cleave only the protein of interest at a specific site, we 
inserted a single methionine r sidue next to the PfCS C-ter coding region 
(Fig. 1A). This insertion provides aCNBr cleavage site between the tag and 
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Fig. 2. Mass spectra of PfCS C-ter polypeptide before CNBr treatment and after 
CNBr treatment. 
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the CSP. Although other chemical cleavage methods can be used, a high 
yield of protein is obtained when 20- to 100-fold molar excess of CNBr is 
used. After IMAC purification, CNBr cleavage of CSP yielded approx 95% 
pure CSP C-ter based on the integration of the peak areas at 214 nm. 
The histidine tag was removed by a second IMAC purification, and 
the product analyzed by chromatography and mass spectrography (Fig. 2). 
A mol/wt of 13'127.1 was determined by mass spectrography analysis 
before CNBr and of 11'459.4 after CNBr treatment. The difference in mole- 
cular weight between these two proteins corresponds exactly to the mole- 
cular weight of the amino acids composing the cleaved sequence, 
demonstrating the specificity and high yield of cleavage at the methionine 
residue interposed between the affinity tag and the desired polypeptide. 
Although methionine is among the less-frequent residues and is often 
removed from the N-terminus of proteins in vivo, its presence within the 
amino acid sequence of the polypeptide will result in cleavage at this site 
and could limit the use of this method. This limitation can be circum- 
vented by replacing internal methionines by alanines, valines, or 
isoleucines, which are known, in most instances, to be conservative 
changes and not to alter drastically the properties of the recombinant 
polypeptide. We replaced two such methionines from the C-terminal CSP 
sequence by valines, using site-directed mutagenesis. It should be noticed 
that internal cleavage sites also represent a major problem in enzyme 
cleavage procedures, like thrombin, sometimes precluding the isolation of 
the protein. Furthermore, it should be pointed out that cystein may be 
slowly oxidized and aspartic acid-proline bonds cleaved after prolonged 
CNBr exposure. Finally, excess reagent can cause degradation of Trp and 
Tyr side chains. However, using the conditions we describe, these modifi- 
cations hould be minor. 
The chemical removal of the purification tag, as exemplified by the 
mass spectrum profiles, could be applied to other amino acids. As an 
alternative to Met/X cleavage, it could be mentioned that Trp/X cleavage 
is also possible in glacial acetic acid and 9 M HC1 in the presence of DMSO 
followed by a CNBr treatment (9). In this case, methionine is not cleaved, 
but is oxidized to methionine sulfoxide. These residues can be then 
reduced by overnight incubation at 37~ with 10% ~-mercaptoethanol to 
obtain original methionine (9). 
The combination of methionine insertion and CNBr cleavage was 
recently described for long synthetic peptide (10). It is potentially applica- 
ble to any recombinant protein production system ranging from viruses to 
eukaryotic expression systems. It is also applicable to tags that can alter 
the chemical properties of the protein, such as hydrophobic tags, polyeth- 
ylene tags, and so forth, circumventing the limitation of using defined 
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peptidic sequence. Considering the high level of expression that is now 
obtained in various ystems and the simple affinity purification protocols 
available, one key step in the production of a recombinant protein is 
removal of tag elements to obtain the desired polypeptide precisely. We 
have shown here such specific and high yield expression and recovery of 
a recombinant polypeptide using a usual affinity chromatography and a 
simple chemical cleavage reaction. Over 95% of the recombinant polypep- 
tide was devoid of the purification tag sequence. This low-cost and 
straightforward approach may easily be used for a variety of recombinant 
proteins. 
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